SETDB1 and hepatocellular carcinoma: Great efforts of high-throughput sequencing have revealed that overexpression, amplification, or activation of SETDB1 plays an oncogenic effect in malignant cancers, including hepatocellular carcinoma [14], melanoma [15], and glioblastoma [16].